iDose TR Administration in an Office-Based Surgery Setting

Part of paid clinical trials in Austin, Texas.

Sponsor
Glaukos Corporation
Study ID
NCT07816692
Status
Recruiting
Apply to this trial

Conditions

  • Ocular Hypertension (OHT)
  • Open Angle Glaucoma (OAG)

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • iDose TR (travoprost intracameral implant) 75 µg — COMBINATION_PRODUCT
    Travoprost-releasing implant preloaded in a sterile, single-use inserter.

Study Details

Clinical in-use observational trial to evaluate the administration of iDose TR (travoprost intracameral implant) in an office-based surgery setting.

Key Dates

First listed
Sep 14, 2026
Start date
May 13, 2026
Status verified
Sep 2026
Primary completion
Mar 31, 2027
Completion
Mar 31, 2027

Study Design

Enrollment
30 participants (estimated)

Arms

  • Arm: iDose TR
    Travoprost Intracameral Implant

Primary Outcome Measure

Successful administration of iDose TR in an office-based surgical setting. [ Time Frame: 3 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Glaukos Investigative SiteAustinTexas78746
Glaukos Investigative Site
[email protected]
949-739-8749

Find similar trials in Austin, TX

By research site
Glaukos Investigative Site· Austin, TX

Related Studies